Using a dye to find sentinel lymph nodes in early ovarian cancer surgery
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial is testing a technique that uses a special dye to find the first lymph nodes where ovarian cancer might spread. It aims to help doctors remove only those sentinel nodes during surgery instead of removing many nodes, which could lead to fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- Your cancer must be early-stage (I or II) based on imaging scans, with no suspicious lymph node enlargement.
- You must be in generally good health, with adequate blood cell counts, kidney, and liver function.
- You must not have had previous surgery on the lymph nodes in your abdomen or pelvis, nor surgery on your abdominal aorta or pelvic blood vessels.
- You must not have had radiation therapy to your abdomen in the past.
- You must not have allergies to indocyanine green (a dye used in this test) or iodine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a technique to find the first lymph nodes that might contain cancer cells during surgery for early-stage ovarian cancer. It aims to see if this method can help doctors remove fewer lymph nodes while still getting important information.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This study tests a way to check for cancer spread in the lymph nodes of the pelvis during surgery for early-stage ovarian cancer. It uses a special dye and tracer to find the first lymph node that drains from the tumor.
This study checks whether doctors can find the first lymph node(s) where ovarian cancer may spread using two dyes (a radioactive tracer and a green dye). It may help surgeons do more precise staging and treatment planning.
This study is testing a blue dye called Patent Blue to see if it can help surgeons find sentinel lymph nodes (the first nodes cancer might spread to) during surgery for early-stage ovarian cancer. The goal is to reduce the need for more extensive lymph node removal, possibly leading to fewer side effects.
Hear when a new Epithelial Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.